Crossmark

Evaluation of the protective efficacy of a spatial repellent to reduce malaria incidence in children in western Kenya compared to placebo: study protocol for a cluster-randomized double-blinded control trial (the AEGIS program)

Crossref DOI link: https://doi.org/10.1186/s13063-022-06196-x

Published Online: 2022-04-05

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ochomo, Eric O.

Gimnig, John E.

Bhattarai, Achuyt

Samuels, Aaron M.

Kariuki, Simon

Okello, George

Abong’o, Bernard

Ouma, Eunice A.

Kosgei, Jackline

Munga, Stephen

Njagi, Kiambo

Odongo, Wycliffe

Liu, Fang

Grieco, John P. https://orcid.org/0000-0002-2080-8598
Achee, Nicole L.
Funding

Funding for this research was provided by:

Unitaid (2018-29-UND)
License Information

Text and Data Mining valid from 2022-04-05

Version of Record valid from 2022-04-05
More Information

Article History

Received: 6 August 2021

Accepted: 24 March 2022

First Online: 5 April 2022

Declarations

:

: Protocol approved by the KEMRI SERU (protocol 3870, reference KEMRI/RES/7/3/1), the Institutional Review Boards of CDC (protocol number: 7252), UND (protocol number: 19-08-5506), and the WHO ERC (ERC.0003185). Informed consent to participate will be conducted with all participants.

: Not applicable—manuscript does not include any details, images, or videos relating to an individual person.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below